The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Myocardial ischemia in patients with hypertrophic cardiomyopathy: contribution of inadequate vasodilator reserve and elevated left ventricular filling pressures.
Open accessAbstract
To study the mechanism and hemodynamic significance of myocardial ischemia in hypertrophic cardiomyopathy, 20 patients (nine with resting left ventricular outflow tract obstruction greater than or equal to 30 mm Hg) with a history of angina pectoris and angiographically normal coronary arteries underwent a pacing study with measurement of great cardiac vein flow, lactate and oxygen content, and left ventricular filling pressure. Compared with 28 control subjects without hypertrophic cardiomyopathy, their resting coronary blood flow was higher (91 +/- 27 vs 66 +/- 17 ml/min; p less than .001) and their coronary resistance was lower (1.13 +/- 0.38 vs 1.55 +/- 0.45 mm Hg/ml/min; p less than .001). Left ventricular end-diastolic pressure (16 +/- 6 vs 11 +/- 3 mm Hg; p less than .001) and pulmonary arterial wedge pressure (13 +/- 5 vs 7 +/- 3 mm Hg; p less than .001) were significantly higher in patients with hypertrophic cardiomyopathy. During pacing, coronary flow rose in both groups, although coronary and myocardial hemodynamics differed greatly. In contrast to the linear increase in flow in control subjects up to heart rate of 150 beats/min (66 +/- 17 to 125 +/- 28 ml/min), patients with hypertrophic cardiomyopathy demonstrated an initial rise in flow to 133 +/- 31 ml/min at an intermediate heart rate of 130 beats/min. At this point, 12 of 20 patients developed their typical chest pain. With continued pacing to a heart rate of 150 beats/min, mean coronary flow fell to 114 +/- 29 ml/min (p less than .002), with 18 of 20 patients experiencing their typical chest pain and metabolic evidence of myocardial ischemia. This fall in coronary flow was associated with a substantial rise in left ventricular end-diastolic pressure (30 +/- 9 mm Hg immediately after peak pacing). In the 14 patients whose coronary flow actually fell from intermediate to peak pacing, the rise in left ventricular end-diastolic pressure in the same interval was greater than that of the six patients whose flow remained unchanged or increased (11 +/- 8 vs 2 +/- 2 mm Hg; p less than .01). In addition, despite metabolic and hemodynamic evidence of myocardial ischemia, the arteriovenous O2 difference actually narrowed at peak pacing. Thus most patients with hypertrophic cardiomyopathy achieved maximum coronary vasodilation and flow at modest increases in heart rate. Elevation in left ventricular filling pressure, probably related to ischemia-induced changes in ventricular compliance, was associated with a decline in coronary flow.(ABSTRACT TRUNCATED AT 400 WORDS)
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Relation of Structure to Function of the Tissues of the Wall of Blood Vessels
Burton, A. C. (1954) · Physiological Reviews · doi:10.1152/physrev.1954.34.4.619 · Cited by 798
Maron, B. J., Gottdiener, J. S., & Epstein, S. E. (1981) · The American Journal of Cardiology · doi:10.1016/0002-9149(81)90068-0 · Cited by 607
Self-citationMarcus, M. L., Doty, D. B., Hiratzka, L. F., Wright, C. B., & Eastham, C. L. (1982) · New England Journal of Medicine · doi:10.1056/nejm198211253072202 · Cited by 580
Hemodynamics of collapsible vessels with tone: the vascular waterfall
Permutt, S., & Riley, R. L. (1963) · Journal of Applied Physiology · doi:10.1152/jappl.1963.18.5.924 · Cited by 545
Marbach, E. P., & Weil, M. H. (1967) · PubMed · Cited by 480
Rapid Enzymatic Measurement of Blood Lactate and Pyruvate
Marbach, E. P., & Weil, M. H. (1967) · Clinical Chemistry · doi:10.1093/clinchem/13.4.314 · Cited by 395
Maron, B. J., Epstein, S. E., & Roberts, W. C. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90139-5 · Cited by 385
Self-citationOpherk, D., Mall, G., Zebe, H., Schwarz, F., Weihe, E., Manthey, J., & Kübler, W. (1984) · Circulation · doi:10.1161/01.cir.69.1.1 · Cited by 381
Pathophysiology of chest pain in patients with cardiomyopathies and normal coronary arteries.
Pasternac, A., Noble, J., Streulens, Y., Elie, R., Henschke, C., & Bourassa, M. G. (1982) · Circulation · doi:10.1161/01.cir.65.4.778 · Cited by 241
Bonow, R. O., Ostrow, H. G., Rosing, D. R., Cannon, R. O., Lipson, L. C., Maron, B. J., Kent, K. M., Bacharach, S. L., & Green, M. V. (1983) · Circulation · doi:10.1161/01.cir.68.5.1062 · Cited by 127
Self-citation
Cited by
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citation2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.06.011 · Cited by 1,276
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citationThe Management of Hypertrophic Cardiomyopathy
Spirito, P., Seidman, C. E., McKenna, W. J., & Maron, B. J. (1997) · New England Journal of Medicine · doi:10.1056/nejm199703133361107 · Cited by 1,007
Self-citationOmmen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.044 · Cited by 994
Maron, B. J., Bonow, R. O., Cannon, R. O., Leon, M. B., & Epstein, S. E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198703263161305 · Cited by 896
Self-citationHypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review
Wigle, E. D., Sasson, Z., Henderson, M. A., Ruddy, T. D., Fulop, J., Rakowski, H., & Williams, W. G. (1985) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(85)90024-6 · Cited by 823
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · Circulation · doi:10.1161/cir.0000000000001250 · Cited by 807
Coronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 782
Hypertrophic Cardiomyopathy: Clinical Spectrum and Treatment
Wigle, E. D., Rakowski, H., Kimball, B. P., & Williams, W. G. (1995) · Circulation · doi:10.1161/01.cir.92.7.1680 · Cited by 778
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 756
Self-citation2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy
Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., Kantor, P., et al. (2020) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2020.08.045 · Cited by 643
Writing Committee Members, Ommen, S. R., Mital, S., Burke, M. A., Day, S. M., Deswal, A., Elliott, P., Evanovich, L. L., Hung, J., Joglar, J. A., et al. (2020) · Circulation · doi:10.1161/cir.0000000000000937 · Cited by 605
Elliott, P., & McKenna, W. J. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16358-7 · Cited by 498
Hozumi, T., Yoshida, K., Akasaka, T., Asami, Y., Ogata, Y., Takagi, T., Kaji, S., Kawamoto, T., Ueda, Y., & Morioka, S. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00389-1 · Cited by 426
Basso, C. (2000) · Human Pathology · doi:10.1053/hupa.2000.16659 · Cited by 418
Shirani, J., Pick, R., Roberts, W. C., & Maron, B. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00492-1 · Cited by 408
Self-citation2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy
Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., et al. (2024) · JACC · doi:10.1016/j.jacc.2024.02.014 · Cited by 382
Nagueh, S. F., Bierig, S. M., Budoff, M. J., Desai, M., Dilsizian, V., Eidem, B., Goldstein, S. A., Hung, J., Maron, M. S., Ommen, S. R., et al. (2011) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2011.03.006 · Cited by 347
Camici, P., Chiriatti, G., Lorenzoni, R., Bellina, R. C., Gistri, R., Italiani, G., Parodi, O., Salvadori, P. A., Nista, N., Papi, L., et al. (1991) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(91)90869-b · Cited by 337
Houghton, J. L., Frank, M. J., Carr, A. A., von Dohlen, T. W., & Prisant, L. M. (1990) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(90)90173-m · Cited by 328
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2011.10.020 · Cited by 322
Self-citationSpirito, P., Maron, B. J., Bonow, R. O., & Epstein, S. E. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90998-2 · Cited by 310
Self-citationThe Case for Myocardial Ischemia in Hypertrophic Cardiomyopathy
Maron, M. S., Olivotto, I., Maron, B. J., Prasad, S. K., Cecchi, F., Udelson, J. E., & Camici, P. G. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.04.072 · Cited by 307
Self-citationPacing in hypertrophic obstructive cardiomyopathy: A randomized crossover study
Kappenberger, L., Linde, C., Daubert, C., McKenna, W., Meisel, E., Sadoul, N., Chojnowska, L., Guize, L., Gras, D., Jeanrenaud, X., et al. (1997) · European Heart Journal · doi:10.1093/oxfordjournals.eurheartj.a015435 · Cited by 298
Cardim, N., Galderisi, M., Edvardsen, T., Plein, S., Popescu, B. A., D'Andrea, A., Bruder, O., Cosyns, B., Davin, L., Donal, E., et al. (2015) · European Heart Journal – Cardiovascular Imaging · doi:10.1093/ehjci/jeu291 · Cited by 284
Dilsizian, V., Bonow, R. O., Epstein, S. E., & Fananapazir, L. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90193-5 · Cited by 279
Self-citationMyocardial Bridging in Children with Hypertrophic Cardiomyopathy — A Risk Factor for Sudden Death
Yetman, A. T., McCrindle, B. W., MacDonald, C., Freedom, R. M., & Gow, R. (1998) · New England Journal of Medicine · doi:10.1056/nejm199810223391704 · Cited by 267
Hypertrophic obstructive cardiomyopathy
Veselka, J., Anavekar, N. S., & Charron, P. (2017) · The Lancet · doi:10.1016/s0140-6736(16)31321-6 · Cited by 257
Providencia, R., Elliott, P., Patel, K., McCready, J., Babu, G., Srinivasan, N., Bronis, K., Papageorgiou, N., Chow, A., Rowland, E., et al. (2016) · Heart · doi:10.1136/heartjnl-2016-309406 · Cited by 122
Metadata
- Authors
- Cannon, R. O., Rosing, D. R., Maron, B. J., Leon, M. B., Bonow, R. O., Watson, R. M., & Epstein, S. E.
- Venue
- Circulation
- Published
- 1985-02
- Volume
- 71
- Issue
- 2
- Pages
- 234-243
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2095094855
- Cited by
- 477
- References
- 14
- FWCI
- 11.65
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.